ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OSUR OraSure Technologies Inc

4.30
0.00 (0.00%)
Pre Market
Last Updated: 13:50:42
Delayed by 15 minutes
Share Name Share Symbol Market Type
OraSure Technologies Inc NASDAQ:OSUR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.30 4.22 4.35 1 13:50:42

OraSure Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum

08/11/2018 11:00am

GlobeNewswire Inc.


OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more OraSure Technologies Charts.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technologies & Diagnostics Forum.  The conference will be simultaneously webcast over the Internet.

Dr. Tang is scheduled to speak on November 15, 2018, at approximately 1:00 PM Eastern Time (10:00 AM Pacific Time).  Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com, and clicking on the Investor Info link.  A replay of the webcast will be available on OraSure Technologies’ web site for seven days.  Alternatively, you can access the live webcast of the presentation via the following link: http://wsw.com/webcast/canaccord32/osur/.

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral fluid sample collection, and stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.  For more information on OraSure Technologies, please visit www.orasure.com.

Company contact:

Roberto CucaJeanne Mell
Chief Financial OfficerVP Corporate Communications
610-882-1820610-882-1820
  
Investorinfo@orasure.commedia@orasure.com
www.orasure.comwww.orasure.com

1 Year OraSure Technologies Chart

1 Year OraSure Technologies Chart

1 Month OraSure Technologies Chart

1 Month OraSure Technologies Chart